Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 20:11:621099.
doi: 10.3389/fphar.2020.621099. eCollection 2020.

Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach

Sajad Fakhri  1 , Sana Piri  1 , Mohammad Bagher Majnooni  2 , Mohammad Hosein Farzaei  1 , Javier Echeverría  3
Affiliations
Review

Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach

Sajad Fakhri et al. Front Pharmacol. .

Abstract

The novel coronavirus 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a wide range of manifestations. In this regard, growing evidence is focusing on COVID-19 neurological associations; however, there is a lack of established pathophysiological mechanisms and related treatments. Accordingly, a comprehensive review was conducted, using electronic databases, including PubMed, Scopus, Web of Science, and Cochrane, along with the author's expertize in COVID-19 associated neuronal signaling pathways. Besides, potential phytochemicals have been provided against neurological signs of COVID-19. Considering a high homology among SARS-CoV, Middle East Respiratory Syndrome and SARS-CoV-2, revealing their precise pathophysiological mechanisms seems to pave the road for the treatment of COVID-19 neural manifestations. There is a complex pathophysiological mechanism behind central manifestations of COVID-19, including pain, hypo/anosmia, delirium, impaired consciousness, pyramidal signs, and ischemic stroke. Among those dysregulated neuronal mechanisms, neuroinflammation, angiotensin-converting enzyme 2 (ACE2)/spike proteins, RNA-dependent RNA polymerase and protease are of special attention. So, employing multi-target therapeutic agents with considerable safety and efficacy seems to show a bright future in fighting COVID-19 neurological manifestations. Nowadays, natural secondary metabolites are highlighted as potential multi-target phytochemicals in combating several complications of COVID-19. In this review, central pathophysiological mechanisms and therapeutic targets of SARS-CoV-2 has been provided. Besides, in terms of pharmacological mechanisms, phytochemicals have been introduced as potential multi-target agents in combating COVID-19 central nervous system complications.

Keywords: COVID-19; SARS-CoV-2; coronaviruses; nervous system; neurology; pharmacology; phytochemicals; signaling pathways.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Chemical structures of selected polyphenols/flavonoids with the potential of being used against COVID-19 neurological manifestations.
FIGURE 2
FIGURE 2
Chemical structures of selected alkaloids/terpenes/quinones with the potential of being used against COVID-19 neurological manifestations.
FIGURE 3
FIGURE 3
The neurological manifestations in COVID-19, related pathophysiological mechanisms, and promising role of phytochemicals. COVID-19: coronavirus 2019, PLpro: papain-like protease, RdRP: RNA-dependent RNA polymerase, SARS-CoV-2: severe acute respiratory syndrome coronavirus 2, TMPRSS2: transmembrane protease, serine 2, 3CLpro: 3-chymotrypsin-like cysteine protease.
See this image and copyright information in PMC

References

    1. Abbaszadeh F., Fakhri S., Khan H. (2020). Targeting apoptosis and autophagy following spinal cord injury: therapeutic approaches to polyphenols and candidate phytochemicals. Pharmacol. Res. 160, 105069. 10.1016/j.phrs.2020.105069 - DOI - PubMed
    1. Abd El-Aziz N. M., Shehata M. G., Awad O. M. E., El-Sohaimy S. A. (2020). Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis. Research Square [Pre-print]. 10.21203/rs.3.rs-25850/v1 - DOI
    1. Adem S., Eyupoglu V., Sarfraz I., Rasul A., Ali M. (2020a). Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA. Preprints. 10.20944/preprints202003.0333.v1 - DOI - PMC - PubMed
    1. Adem Ş., Eyupoglu V., Sarfraz I., Rasul A., Zahoor A. F., Ali M., et al. (2020b). Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine 33, 153310. 10.1016/j.phymed.2020.153310 - DOI - PMC - PubMed
    1. Ahmad I., Rathore F. A. (2020). Neurological manifestations and complications of COVID-19: a literature review. J. Clin. Neurosci. 77, 8–12. 10.1016/j.jocn.2020.05.017 - DOI - PMC - PubMed

LinkOut - more resources